Global health body, the World Health Organization (WHO) is currently concluding plans for its “Solidarity Trial Treatment” for COVID19 in over 100 countries of the world.

The trial treatment is part of its efforts to develop effective treatment regimen and vaccine to combat COVID19 infection ravaging the world.

Nigeria’s Minister of Health, Dr. Osagie Ehanire, had on Monday disclosed that the “Federal Government is cooperating with the WHO on treatment regimen solidarity trial with the following states enrolled; Lagos, Ogun, Kaduna, Sokoto, Kano and the Federal Capital Territory (FCT).”

The Minister, who spoke in Abuja during a briefing by the Presidential Task Force (PTF) on COVID-19, however, did not state when the trial will begin and the modalities for it.

More than 1,200 patients have been randomised from the first five countries to evaluate the safety and efficiency of the drug combinations, it was learnt.

According to the agency, “the Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19”.

By enrolling patients in multiple countries, the Solidarity Trial Treatment aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence.

The international health body added that “As of April 21 2020, over 100 countries are working together to find effective therapeutics as soon as possible, via the trial.

“The greater the number of participating countries, the faster results will be generated.

WHO is facilitating access to thousands of treatment courses for the trial through donations from a number of manufacturers.

“Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them.”

The minister said Nigeria has conducted 27,078 COVID-19 tests with 4,399 cases in 34 states and the FCT.

He gave the ratio of infection as 70% for men to 30 per cent for women.

Dr. Ehanire added: “Kogi and Cross River States have not reported any cases, but we are optimistic that we can work with the State Health Ministry to validate this in due course, when we engage the state authorities.

“A team from the Ministry of Health, made up of experts from various specialties, including the Nigeria Centre for Disease Control (NCDC), is on standby to proceed to Calabar as soon as travel arrangements can be made, taking with them, resource to support the health system.

“Senior management of the Federal Ministry of Health and clinical case managers in our hospitals, this morning participated in a multinational teleconference with Chinese medical and academic experts in Beijing, where much insight was gained into the treatment strategy of China and other matters of common interest were discussed.

“The learnings from this intervention are invaluable in reexamining our methods.

“It is important that our response to COVID-19 be a concerted national, collaborative drive, to stand a better chance of being effective.

“So far, our efforts are yielding result as shown in states where panic and scare were initially rife, but now subsumed”, the Minister said.